BioXcel Therapeutics, Inc. (BTAI) BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company’s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates. Astria Therapeutics, Inc. (ATXS) Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization […]
Read MoreCollegium Pharmaceutical, Inc. (COLL) Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone. General Mills, Inc. (GIS) General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores […]
Read MoreBuy Price: $5.15 or better Sell Price: TradersPro Sell Signal Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans. The stocks founds in the One Hot […]
Read MoreSince before 2020, I’ve been writing about the wisdom in being very selective about the investments you make. That includes taking a defensive approach by looking for industries and businesses whose operations aren’t as sensitive to the and ebb and flow of economic growth. Prepackaged food stocks like Hormel Foods Corp (HRL), CPB, and KHC […]
Read More(Bloomberg) — BlackRock Inc. strategists say traders that have started to bet on a sharp slowdown in inflation are setting themselves up for disappointment. While they acknowledge that prices pressures are ebbing faster than expected, they contest consensus bets that see the rate tumbling toward the Federal Reserve’s 2% target. That’s leading the world’s biggest […]
Read MoreMarket conditions are Bearish in a Bear Market as of 2022-12-16. This means traders and investors should consider trading with a Bearish bias by shorting stocks, buying inverse-ETF’s or buying put options. The rank of the Bear Market is -13.50 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read More(Bloomberg) — US equities are set for their worst year since the global financial crisis, and, according to Morgan Stanley strategist Michael Wilson, corporate profits are about to meet the same fate. A looming earnings recession “by itself could be similar to what transpired in 2008/2009,” said Wilson. That could spark a new stock-market low […]
Read More(Bloomberg) — A brutal year for US stocks is drawing to a close with little conviction on Wall Street that the outlook is brightening anytime soon. After charting a rebound since October on speculation the Federal Reserve is nearing the end of its most aggressive rate hikes in decades, stock prices have retreated over the […]
Read MoreAkero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company’s lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. […]
Read More(Bloomberg) –Private equity will have to get the check book out in the coming months if the industry wants to return to its record pace of deal making. That’s because banks stuck with billions of dollars of risky corporate loans, a hangover from deals underwritten in a lower-rate environment, are unlikely to back sizable new […]
Read More(Bloomberg) — European bondholders are coming to terms with the fact that this year’s devastating losses may have further to run in 2023. The worst-ever year for the region’s bonds is ending with one of the most brutal sell-offs in months, after a chorus of central bankers warned investors that interest rates will rise more […]
Read More(Bloomberg) — The world’s biggest money managers are set to unload up to $100 billion of stocks in the final few weeks of the year, adding to a selloff that’s snowballed since Jerome Powell’s unequivocal message that policymakers will press on with aggressive tightening at the risk of job cuts and a recession. Notwithstanding their […]
Read MoreCal-Maine Foods, Inc., together with its subsidiaries, produces, grades, packages, markets, and distributes shell eggs. The company offers specialty shell eggs, such as nutritionally enhanced, cage free, organic, and brown eggs under the Egg-Land’s Best, Land O’ Lakes, Farmhouse Eggs, and 4-Grain brand names, as well as under private labels CALM $60.0300 1.7500 % 3.0000 […]
Read More(Bloomberg) — For all its twists and turns, the 2022 market has also been a story of patterns repeating. Stocks fall, shorts cover, quants buy, then everyone jumps back in just in time to get torched. It’s happening again. After a month of drawing down positions, investors poured $25 billion in stocks in the week […]
Read More